Warnex Inc.

Warnex Inc.

November 21, 2005 14:03 ET

Warnex appoints two new directors

LAVAL, QC, Nov. 21 - Warnex Inc. (TSX:WNX) is pleased to announce
that Mr. Daniel Boulais and Ms. Diane Lanctôt have recently joined the Board
of Directors of Warnex. They replace Hubert Carrier, former Interim Group Vice
President of SGF Soquia Inc., who recently tendered his resignation as
Director of Warnex, and Denis Huard, President and General Manager of CDMV
Inc., who did not present himself for reelection at the last Annual Meeting of
Shareholders. These two new Board members were recommended as candidates by
SGF Soquia, in accordance with a Shareholders' Agreement amongst main
shareholders of Warnex Inc. dated July 10, 2002 (this Shareholders' Agreement
may be consulted on www.sedar.com).

Warnex also announces that Dr. Susan Harlander has resigned from Warnex's
Scientific Advisory Board due to a new direction in her professional career.

Mr. Daniel Boulais is the Senior Vice-President, Investments, Agri-Food,
for the Société générale de financement du Québec ("SGF"). Mr. Boulais has
more than 20 years of experience working with international companies in the
agri-food industry. He is known for his solid strategic vision, his ability to
apply that vision on an operational level, and his keen business sense, which
has allowed him to identify and successfully exploit numerous business
opportunities across North America.

Prior to joining SGF, he was the President and Chief Operating Officer,
from 2001 to 2004, and Vice-President Marketing, Research and Development and
International Sales, from 1999 to 2001, of Saputo's Bakery Division. From 1979
to 1999, he held various positions of major food companies, including Culinar,
Pepsi-Cola Canada, Nestle Enterprises Ltd., and Canada Packers.

Ms. Diane Lanctôt has been the President of Lanctôt Ltd. since 1981, and
is also a member of SGF's Board of Directors. With over 20 years experience,
Ms. Lanctôt has extensive expertise in business management and product
distribution. Lanctôt Ltd. specializes in the design, production and
distribution of sports clothing and other products, as well as the
distribution of ophthalmic frames and sunglasses. The company distributes
several prestigious European brand names such as Vuarnet, Mexx and Rainforest.
From 1986 to 1989, Ms. Lanctôt was also Executive Vice President of Vuarnet

About Warnex

Warnex (www.warnex.ca) is a publicly traded (TSX: WNX) Canadian
biotechnology company devoted to protecting public health by providing
advanced diagnostic and quality control products and services to the
pharmaceutical, agri-food, and healthcare sectors. Warnex's genomics-based
technology offers a versatile detection platform that produces accurate
results rapidly, using Real-Time PCR technology combined with unique genetic
markers and software. Applications range from pathogen detection in foods to
GMO testing. Our development pipeline includes applications in the detection
of viruses, toxins, yeasts, and fungi, as well as meat speciation and
bioterrorism. Warnex's profitable and growing analytical, bioanalytical, and
clinical service groups offer a variety of quality control services, method
development and validation, contract R&D, bioavailability and bioequivalence
studies for clinical trials, and medical laboratory testing.

Warnex is a trademark of Warnex Inc.


Certain statements contained in this news release are forward-looking and
are subject to numerous risks and uncertainties, known and unknown. For
information identifying known risks and uncertainties, relating to the early
commercialization of Warnex products, intellectual property and licensing, R&D
of new Warnex products, manufacturing and laboratory facilities, suppliers,
key employees, key customers, financial resources and credit risk, government
regulations, foreign currency risk and volatility of share price, and other
important factors that could cause actual results to differ materially from
those anticipated in the forward-looking statements, please refer to the
heading Risks and Uncertainties in the Management's Discussion and Analysis
for the third quarter ended on September 30, 2005, which can be found at
www.sedar.com. Consequently, actual results may differ materially from the
anticipated results expressed in these forward-looking statements.

Contact Information